Skinhealth Systems (SKIN) reported $301M in revenue for fiscal 2025, −10.0% year on year. That ranks #2477 by revenue among 2853 SEC filers and #248 in Healthcare. It posted a net loss of −$9.5M for the same year. Revenue has grown 10.3% a year on average since 2019 ($167M then). The fiscal 2025 balance sheet shows $500M in total assets, $233M in cash and $552M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $301M | −10.0% | FY20252025-12-31 |
| Gross profitGrossProfit | $196M | +7.7% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | −$20.8M | +$47.0M | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$9.5M | +$19.6M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $37.5M | +132.3% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $303,000 | −59.9% | FY20252025-12-31 |
| Total assetsAssets | $500M | −27.1% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $61.1M | +17.9% | FY20252025-12-31 |
| CashCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $233M | −37.1% | FY20252025-12-31 |
| Long-term debtLongTermDebt | $552M | — | FY20242024-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $64.9M | −$6.6M | Open → |
| Q2 20262026-06-30 | $72.1M | −$2.7M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Profile
- Legal name
- Skinhealth Systems Inc.
- Ticker
- SKIN
- Exchange
- Nasdaq
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 12-31
- CIK
- 0001818093
Filings
- 10-QAug 6, 2026Open filing →
- 10-QMay 7, 2026Open filing →
- 10-KMar 12, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| CormedixCRMD | $312M | $163M |
| Procept BioroboticsPRCT | $308M | −$95,572 |
| BilliontooneBLLN | $305M | $7.5M |
| Skinhealth SystemsSKIN | $301M | −$9.5M |
| EvolusEOLS | $297M | −$51.6M |
| Ironwood PharmaceuticalsIRWD | $296M | $24.0M |
| Rigel PharmaceuticalsRIGL | $294M | $367M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Skinhealth Systems — Key figures |url=https://companiesranked.com/en/company/skinhealth-systems |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Skinhealth Systems — Key figures. CompaniesRanked. https://companiesranked.com/en/company/skinhealth-systemsBibTeX
@misc{companiesranked-en-company-skinhealth-systems-2026,
author = {{CompaniesRanked}},
title = {{Skinhealth Systems — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/skinhealth-systems}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-017376 · March 12, 2026
{{cite web |title=Skinhealth Systems — Key figures — 10-K (0001628280-26-017376) |url=https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/skin-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-12}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.